Tumour cells need sugar to grow. Blocking two specific proteins that transport sugar could slow down the growth of lung tumours. Initial trials by researchers at the Swiss Federal Institute of Technology in Lausanne (EPFL) are promising.
The idea of ‘starving’ cancer cells by blocking so-called glucose transporters to deprive them of access to sugar is an obvious therapeutic approach. It was unclear how glucose transporters should be blocked and whether cancer cells would switch to alternative energy sources in the absence of sugar.
To answer these questions, the researchers bred mice with lung cancer that lacked the glucose transporters Glut1 and Glut3. Their tumours consumed less sugar, grew more slowly and the mice lived longer than their counterparts. In a further step, Glut1 and Glut3 were eliminated from four different human lung cancer cell lines grown in the laboratory, whereupon these cells also slowed their growth. It appears that both glucose transporters are necessary to nourish the tumour. The next step will involve further work to investigate these metabolic pathways in greater detail.
Reference:
ETH Lausanne
, ‘Blocking sugar metabolism slows lung tumour growth’, eLife, 23 June 2020, DOI: 10.7554/eLife.53618
, https://elifesciences.org/articles/53618